AIM: To verify the usefulness of FibroQ for predicting fi brosis in patients with chronic hepatitis C, compared with other noninvasive tests. METHODS: This retrospective cohort study included 237 consecutive patients ...AIM: To verify the usefulness of FibroQ for predicting fi brosis in patients with chronic hepatitis C, compared with other noninvasive tests. METHODS: This retrospective cohort study included 237 consecutive patients with chronic hepatitis C who had undergone percutaneous liver biopsy before treatment. FibroQ, aspartate aminotransferase (AST)/alanine aminotransferase ratio (AAR), AST to platelet ratioindex, cirrhosis discriminant score, age-platelet index (API), Pohl score, FIB-4 index, and Lok's model were calculated and compared. RESULTS: FibroQ, FIB-4, AAR, API and Lok's model results increased significantly as fibrosis advanced (analysis of variance test: P < 0.001). FibroQ trended to be superior in predicting signifi cant fi brosis score in chronic hepatitis C compared with other noninvasive tests. CONCLUSION: FibroQ is a simple and useful test for predicting signifi cant fi brosis in patients with chronic hepatitis C.展开更多
基因测试与筛查（genetic testing and screen—ing）为基因诊断提出相关预防和治疗措施对个体可能存在的某些遗传特性和遗传疾病有关的基因进行测试。测试与筛查是同步的，筛查以测试为前提，测试的过程同时实现筛查的目的。基因测试...基因测试与筛查（genetic testing and screen—ing）为基因诊断提出相关预防和治疗措施对个体可能存在的某些遗传特性和遗传疾病有关的基因进行测试。测试与筛查是同步的，筛查以测试为前提，测试的过程同时实现筛查的目的。基因测试与筛查包括生殖遗传检查、新生儿遗传检测、人口检测及公共卫生方面的预测性遗传检查等。展开更多
基金Supported by Clinical Study Project XMRP, No. CMRPG 690081, from Chiayi Chang Gung Memorial Hospital
文摘AIM: To verify the usefulness of FibroQ for predicting fi brosis in patients with chronic hepatitis C, compared with other noninvasive tests. METHODS: This retrospective cohort study included 237 consecutive patients with chronic hepatitis C who had undergone percutaneous liver biopsy before treatment. FibroQ, aspartate aminotransferase (AST)/alanine aminotransferase ratio (AAR), AST to platelet ratioindex, cirrhosis discriminant score, age-platelet index (API), Pohl score, FIB-4 index, and Lok's model were calculated and compared. RESULTS: FibroQ, FIB-4, AAR, API and Lok's model results increased significantly as fibrosis advanced (analysis of variance test: P < 0.001). FibroQ trended to be superior in predicting signifi cant fi brosis score in chronic hepatitis C compared with other noninvasive tests. CONCLUSION: FibroQ is a simple and useful test for predicting signifi cant fi brosis in patients with chronic hepatitis C.
文摘基因测试与筛查（genetic testing and screen—ing）为基因诊断提出相关预防和治疗措施对个体可能存在的某些遗传特性和遗传疾病有关的基因进行测试。测试与筛查是同步的，筛查以测试为前提，测试的过程同时实现筛查的目的。基因测试与筛查包括生殖遗传检查、新生儿遗传检测、人口检测及公共卫生方面的预测性遗传检查等。
